Loading clinical trials...
Loading clinical trials...
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis
Conditions
Interventions
Experimental: SNF472
Placebo Comparator: Placebo
+1 more
Locations
58
United States
AKDHC Medical Research Services
Phoenix, Arizona, United States
California Institute of Renal Research
El Centro, California, United States
California Institute of Renal Research
Escondido, California, United States
Kidney Disease Medical Group
Glendale, California, United States
DaVita Clinical Research
Lynwood, California, United States
Apex Research of Riverside
Riverside, California, United States
Start Date
February 12, 2020
Primary Completion Date
October 24, 2022
Completion Date
October 24, 2022
Last Updated
February 20, 2024
NCT04592640
NCT03032835
NCT06065852
NCT02854046
NCT01578382
NCT02278692
Lead Sponsor
Sanifit Therapeutics S. A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions